Broad Institute, Inc. Transfers Shares of Verve Therapeutics Inc (VERV) — SEC Form 4, Jun 23, 2021

SEC Form 4 · No Market Transaction
Other Transaction

Non-market transaction reported.

Reporting Owner
TXN 2021-06-21 · FILED 2021-06-23
Equity Position 810K sh 421,954 → 809,784
Equity Change +91.9% shares held after vs before
Filing Lag 2 business days within 2-day SEC deadline
Form 4 · Statement of Changes in Beneficial Ownership
Filing Date
2021-06-23
Report Date
2021-06-21
Accession No.
0000899243-21-025525
Accepted At
2021-06-23 18:13 UTC
Reporting Owner
Name Relationship
Broad Institute, Inc. CIK 0001866851
10% Owner
Non-Derivative Securities Transactions
Title Date Type Shares Price Net Total Post-Txn Ownership
Common StockF1 2021-06-21 J - Other 387,830 A $0.00 — 809,784 Direct
Footnotes (1)
F1
These shares were issued upon the closing of the Issuer's initial public offering in satisfaction of contractual obligations, based on the initial public offering price of $19.00 per share, without payment of any additional consideration by The Broad Institute, Inc. at the time of issuance. Show more
5%+ Holders · 13D/G 4 filers
Other insiders at Verve Therapeutics Inc
All Verve Therapeutics Inc insider activity
GET /v1/forms/4/0000899243-21-025525 API docs
View Original SEC Filing